Abstract-A family of 3 multifunctional intracardiac imaging and electrophysiology (EP) mapping catheters has been in development to help guide diagnostic and therapeutic intracardiac EP procedures. The catheter tip on the first device includes a 7.5 MHz, 64-element, side-looking phased array for high resolution sector scanning. The second device is a forward-looking catheter with a 24-element 14 MHz phased array. Both of these catheters operate on a commercial imaging system with standard software. Multiple EP mapping sensors were mounted as ring electrodes near the arrays for electrocardiographic synchronization of ultrasound images and used for unique integration with EP mapping technologies. To help establish the catheters' ability for integration with EP interventional procedures, tests were performed in vivo in a porcine animal model to demonstrate both useful intracardiac echocardiographic (ICE) visualization and simultaneous 3-D positional information using integrated electroanatomical mapping techniques. The catheters also performed well in high frame rate imaging, color flow imaging, and strain rate imaging of atrial and ventricular structures. The companion paper of this work discusses the catheter design of the side-looking catheter with special attention to acoustic lens design. The third device in development is a 10 MHz forward-looking ring array that is to be mounted at the distal tip of a 9F catheter to permit use of the available catheter lumen for adjunctive therapy tools.
I. Introduction
I ntracardiac echocardiography (ICE) imaging catheters are increasingly being used to guide interventional electrophysiology (EP) therapeutic procedures because they offer real-time, direct observations and improved procedural guidance over that of fluoroscopy alone [1] . Improved interventional image guidance can certainly lead to improved clinical outcomes. Recent reports have shown procedural improvements for atrial fibrillation using ICE integrated with other available imaging modalities [2] , [3] . We have taken this integration approach by building and testing a multifunctional catheter capable of both EP sensing and ICE imaging functions.
A. Arrhythmias and Interventional Procedures in Electrophysiology
Atrial fibrillation (AF), the most common cardiac dysrhythmia, now affects more than 2.2 million adults in the United States alone and was the discharge diagnosis for 465,000 hospitalizations in 2003 [4] . Because cardiac dysrhythmia is more prevalent in ages beyond 60 years, the yearly rate of increase in the patient population with AF is expected to peak by 2030 due to the growing population of aging baby boomers, resulting in an expected 5.6 million U.S. patients by 2050 [5] .
Nonpharmacologic therapies using catheter-based procedures are becoming more common to treat both left and right side superventricular arrhythmias. Many successful catheter-based interventional procedures to treat superventricular arrhythmias have evolved from invasive surgical techniques developed in the 1980s. In the late 1990s, there was a transition to radiofrequency ablation catheter-based approaches for many superventricular arrhythmias [6] .
Both atrial chambers can be accessed and treated by minimally invasive catheter-based EP therapies. Catheters are usually inserted into the patient's femoral vein to access the low-pressure right side of the heart. They are typically guided by fluoroscopic means via the inferior vena cava to the right atrium, allowing immediate access to the right atrioventricular (AV) sulcus, the coronary sinus, and sites on the right atrial walls including the atrial septum. By first using EP diagnostic catheters to map heart wall electrical pathways, the interventionalist can then use therapeutic radiofrequency ablation (RFA) catheters to ablate along specific endocardial paths to isolate aberrant electrical conduction paths disturbing normal sinus rhythm. Left atrial procedures to correct AF are more difficult than right side procedures. Common access to the left atrium is achieved by first crossing the thin atrial septal wall and locating the pulmonary vein ostia, typical targets for ablation therapy to correct AF arrhythmias. Currently there are many therapeutic approaches to ablate undesirable endocardial conduction pathways, including catheter devices producing electrical RF energy, high-intensity focused ultrasound energy, laser energy, and even catheters designed to use cryogenic energy absorption techniques [7] - [9] .
B. Conventional Interventional EP Guidance and Early ICE Development
ICE catheter designs have existed for some time [10] , [11] , although multi-site use was not seen until the late 1980s and early 1990s when catheters with wire-driven rotating piezoelectric transducers were used clinically [12] - [15] . These early mechanical ICE catheters [16] were typically large (e.g., 10F), were not directly steerable (needed a steerable sheath), had limited tissue penetration due to a small circular aperture effecting transmitted power and depth of focus, a slow frame rate (30 Hz), and were incapable of high-quality Doppler or tissue velocity imaging (TVI).
A technological progenitor 10F phased-array device has been used in key studies since 2000 [17] - [19] , and in 2005, an 8F version (AcuNav, Siemens Medical Solutions USA, Inc., Malvern, PA) of the device was approved for human use.
C. Opportunities for Interventional Guidance of EP Therapies
To treat atrial fibrillation, ICE can provide important guidance not only identifying key anatomic structures, but also in direct ablation guidance and avoidance of therapeutic procedure complications such as microemboli production during ablation and thrombus formation on sheaths and catheters [2] , [20] . Other complications ICE can help identify include esophageal imaging to avoid atrial-esophageal fistulas [21] , [22] , and phrenic nerve damage in ablations of the right atrium (RA), right superior pulmonary vein (RSPV), or the superior vena cava (SVC) [7] .
Considerable work has been done in a wide range of imaging modalities to produce guidance superior to that of fluoroscopy and endocardial potential mapping alone [2] , [3] . In addition to transesophogeal echocardiography (TEE) and ICE, there are efforts to add other modalities such as multidetector computed tomography (MDCT), magnetic resonance angiography (MRA), and electroanatomical mapping to the guidance tool set for EP.
With the use of MRA-imaging techniques in EP cases, observations have been made regarding the oblong shape of the PV ostia, and as many as 38% of patients observed had unusual anatomical features that may have contributed to their condition. MRA may be useful in post ablation follow-up to screen for PV stenoses [23] . Recent studies have been performed with a canine model to evaluate an image integration system for catheter ablation with 3-D computed tomography (CT) images in real time to explore anatomy-function interconnection theories in AF [24] . Similar integration studies with a multislice CT (MSCT) imaging system and an image integration platform have been reported on human patients in Europe [25] .
A novel method for endocardial electroanatomical mapping based on magnetic field-sensing technology (CARTO, Biosense Webster, Diamond Bar, CA) was reported in the mid-1990s and remains a popular way to combine 3-D spatial position information with the EP mapping data of endocardial surface potentials [26] , [27] . Additional studies using this technology have been conducted [28] showing efficacy as well as the very real potential for reducing fluoroscopy radiation exposure [29] .
To better use electroanatomic visual display features describing a fairly coarse volume-space of a cardiac electrical road-map, a more advanced integrated guidance tool has been developed to combine very precise noninvasive imaging data from preacquired CT or MR images (CartoMerge, Biosense Webster), with reports from several groups [24] , [30] . A new catheter is now offered to integrate ICE and CARTO, the SoundStar (Biosense Webster, Diamond Bar, CA).
Alternative engineering methods have been introduced recently to provide a volumetric cardiovascular image using catheter-based impedance tomography or "electroanatomical mapping" (LocaLisa, Medtronic, Minneapolis, MN, and Ensite NavX, St. Jude Medical, St. Paul, MN). Both of these methods employ the use of lowfrequency electric field gradients, rather than an explicit magnetic field tracking as with the CARTO method. The electric field gradients are detected with simple catheterbased electrodes providing spatial data to calculate an instantaneous back-projected electrode position in 3-D space. Numerous electrodes on many catheters can be tracked in position with reproducible electrode localization to within 1 mm spatial accuracy [31] . An early version of this type of electroanatomical mapping has been shown to provide premapped EP data for post-processing integration with rotational ICE with particular value for anatomically based arrhythmia ablations [32] .
Ultrasound itself has acted as a spatial referencing method using a triangulation approach to establish a 3-D position in body tissue (RPM, Boston Scientific, Natick, MA). Validation studies have reported some success [33] . The growing importance of non-fluoro mapping tools has prompted a recent study comparing some of the more promising mapping systems [34] with particular acknowl-edgment of the attributes pertaining to the NavX mapping technique by the author conducting the comparison study.
D. Fluoroscopic Exposure: Therapeutic Complications and Reduction Need
Significant radiation exposure reduction is a strong motivator in the development of real-time functional guidance methods to improve clinical outcomes and reduce undesirably long fluoroscopic exposures. Since fluoroscopy remains the current standard for EP therapeutic guidance to direct catheter position and movement, the consequence for patients is long periods of radiation exposure during ablation procedures taking as long as 3 h [35] . Average exposure times of 20 min [36] and 22 min [37] for isthmus ablation procedures to correct atrial flutter in the readily accessible right atrium are not uncommon. EP ablation therapy in the LA can expose patients to more than 21 [38] to 50 [39] min of fluoroscopic radiation. An average fluoroscopy exposure time during cardiac resynchronization device implantation procedures can be 35 min or longer [40] . Extensive fluoroscopic exposures can be hazardous to the patient and practitioner alike, especially if the particular fluoroscopy equipment is substandard in minimizing radiation exposure levels.
Although fluoroscopic techniques have been available for years, the first known necrotic injury from radiation did not appear in the medical literature until 1996 [41] . As late as December 2004, the authoritative committee from the American College of Cardiology Foundation, American Heart Association, and the American College of Physicians Task Force on Clinical Competence and Training recommended no firm quantifiable limits on tolerable exposure levels. Recently, in June 2005, the FDA [42] has recommended relatively modest upper limits on fluoroscopic exposure, although there are more restrictive maximums for both patient and operator mandated in the United Kingdom since 2000 [43] .
Although it is convenient to quantify exposure casually in minutes of exposure, the accepted quantification unit of absorbed dose is the gray (Gy), which for diagnostic radiology is also equal to an equivalent dose, the sievert (Sv). The common total exposure metric is taken as the gray per unit time, times an area of exposure, times the time used, usually stated in dose-area-product (DAP) units of centigray centimeter squared, or cGy-cm 2 . A patient undergoing an AF ablation procedure, for example, may experience a DAP exposure of 2590 cGy-cm 2 [36] , and if one assumes a 10 cm square exposure, the total dose is then 0.26 Gy (or 0.26 Sv). For reference, a typical equivalent annual dose of radiation from natural sources is 2.5 mSv; for patients undergoing fluoroscopic exposure of a small region of the body, transient erythema (skin redness) can occur at 2 Sv, permanent skin epilation at 7 Sv, and late onset dermal necrosis at levels above 10 to 12 Sv [41] . For whole body exposure, the Center for Disease Control [44] has determined that the lethal dose for 50% of a population within 60 d of exposure is 2.5 to 5 Gy (i.e., 2.5 to 5 Sv for a fluoroscopic exposure).
The potential for significant radiation exposures is a true concern if there happens to be a case combining a high-exposure fluoroscope with a lengthy procedure in a young patient. An example is given [41] of an atrophic indurated plaque forming two years later on the skin of a 17 year old following an EP ablation procedure that used approximately 100 min of fluoroscopy; the corresponding dose to skin was estimated to be 10 gray. One study [45] conducted as a survey of diagnostic fluoroscopy machines from various hospitals in the Netherlands showed that there were substantial variations in exposure rates, with the highest exposure rate at 15 times that of the least. With the highest-dose fluoroscopic device, a patient could receive 1 Sv in as little as 7 min of exposure. Thus a lengthy, but not uncommon, 50-min procedural exposure with this level of radiation could produce an alarming total equivalent dose of more than 7 Sv to a region of the chest.
There have been only a few studies focused specifically on fluoroscopic radiation exposures to patients during EP procedures; attention to patient exposure rates and measurement accuracy is still in development. One recent study [46] stated that patients undergoing RF ablation procedures for paroxysmal AF with long duration exposures that averaged 57 min produced an effective dose of (only) 0.0011 Sv on average. Improvements in radiation exposimetry in a clinical setting are apparently still in development because another author [47] strongly questions this dubious result.
Serious efforts to diminish unnecessary radiation exposure have been conducted by groups integrating various mapping tools to display electrical data collected along with anatomical 3-D location. The CARTO system has been employed by investigators [35] , [37] , [39] , [48] , all showing significantly decreased radiation exposure. Additionally, the LocaLisa system was used [49] , [50] with 35% and 50% reduction in fluoroscopic radiation exposure, and the NavX system [35] , [36] , [38] , [51] , provided marked reductions that offer compelling rationale for the utility of these guidance systems.
Guiding interventional EP therapies is clearly challenging. Among the issues are: 1) adequate endocardial electrical mapping, 2) identification of appropriate landmarks and recognition of individual variants in anatomy, 3) specific site guidance of ablation devices, and 4) the determination of therapeutic success while the heart is in motion, and importantly, while radiation exposure is held to a minimum.
We are now entering a "virtual anatomy" realm in EP therapeutic guidance where advanced integration of nonfluoroscopic imaging modalities is emerging [52] , [34] . Using imaging modalities such as electroanatomical mapping of the cardiac anatomy, a significant reduction in fluoroscopic exposure can be achieved [35] , [31] , [36] , [38] . We believe that electroanatomical mapping can be integrated into novel intracardiac imaging catheters to add yet another dimension to EP image guidance. Although there are several nonfluoroscopic guidance devices currently avail- able [47] , the NavX system has the very desirable ability to track in 3-D any EP catheter with standard plug connections, making it ideal to use with our family of EP-ICE catheters. This feature makes the integration of 3-D spatial location and ICE imaging on a single catheter a very straightforward proposition.
II. Methods

A. A Family of Integrated ICE Catheters
Our Bioengineering Research Partnership has targeted several integrated imaging catheter designs specifically for electrophysiology therapy guidance. The first of 3 devices, the "HockeyStick" (HS) [53] , is a 9Fr (3 mm) combination EP mapping and ICE catheter designed to be easily deployed with standard introducer sheaths, possess dual direction steering capability, and incorporate fully integrated EP mapping electrodes near the imaging tip. A 64-element array was chosen in the first design to operate at a center frequency in the range of 7 to 12 MHz with a fractional bandwidth of 50% or greater. The design of this catheter is discussed in more detail in the companion paper [54] . The HockeyStick catheter is depicted in Fig. 1 as it has been used in the right side of the pig heart.
The second member of the EP-ICE family is the "MicroLinear" (ML) catheter. The most recent design is a 9Fr EP capable catheter with a 24-element, 14 MHz phased array mounted at the tip for high definition, high-frame rate, forward-looking imaging. A preferred design configuration for the ML catheter will include a metal ablation tip surrounding the distal array allowing both radio-frequency ablation (RFA) and imaging simultaneously. Prototypes of the MicroLinear forward-looking catheter are shown in Fig. 2 and Fig. 3 with our latest design version shown in the latter.
The third device is a 9Fr forward-looking 64 capacitive micromachined ultrasonic transducer (cMUT) element ring array catheter operating at 10 MHz that ultimately will allow the central catheter lumen to be used as a conduit for any of many small wire, fiber, or electroded therapy devices that can be used simultaneously with forwardlooking imaging. The ring array has been used with synthetic aperture imaging techniques in laboratory testing [55] - [57] to demonstrate its usefulness. Work to incorporate this ring design into a catheter is in progress.
B. Animal Studies
Several animal studies using juvenile Yorkshire pigs have been performed to examine the capabilities of the combination catheters. All animal experiments conformed to accepted standards for the use of laboratory animals and were performed under an institutionally approved protocol at Oregon Health and Science University. Tests were proposed to evaluate prototype catheter performance in the areas of mechanical steering and mapping sensor use, imaging compatibility with active RF ablation, visualization and guidance of ablation catheters, observation of ab- Fig. 2 . The forward-looking devices: the MicroLinear catheter prototype is shown (top panels), and the ring array in recent format (middle panels) along with the earlier ring design in its bench testing configuration and as a singulated ring (bottom panels).
lation lesion size and bubble formation, general compatibility with the imaging system platform (Vingmed Vivid 7, GE Healthcare, Horten, Norway), and performance in color flow and strain rate imaging modes.
The multifunctional catheters were introduced in the jugular or femoral vein to advance the catheter to the RA from either the superior vena cava (SVC) or inferior vena cava (IVC), respectively. While in the RA, the HockeyStick catheters can be used to image the left atrium (LA) and the pulmonary veins (PV) of the LA, or the larger left ventricular (LV) or right ventricular (RV) chambers.
A special electrical connection interface unit for the catheters was used to allow the easy bedside connection of the multifunctional catheters to the imaging system. A separate proximal catheter connector was directly connected to an electrical EP sensor signal-processing system near the bedside. The imaging system beamforming setup parameter files were adjusted to allow for a reasonably straightforward adaptation for the use of the imaging catheters on a standard imaging platform without the need for custom software. The ease of operational adaptation permitted as well the use of advanced imaging modes such as strain rate imaging (SRI) at high frame rates. Tissue motion tracking of arrhythmias can be interpreted using SRI data derived from tissue velocity imaging (TVI). Experimental designs were proposed to track multiple spatial velocity gradients at specific heart wall sites by displaying in real time their high fidelity tissue motion (in strain rate as units of time −1 ) to aid in the assessment of sinus rhythm abnormalities.
A NavX electroanatomical mapping system with multiple lead inputs and full 3-D software mapping tools were used to perform both intracardiac volume mapping and integration experiments with the HockeyStick catheter.
III. Results
More than 10 pigs weighing in the range of 34 to 55 kg have been studied. ICE imaging was performed using a Vingmed Vivid 7 ultrasound system in standard imaging modes, including color and pulsed Doppler, tissue Doppler, TVI, SRI, and tissue synchronization (TSI) imaging. High frame rates were commonly used at 150 F/sec. Digital scan line data were transferred to an offline EchoPAC-PC (GE Healthcare, Milwaukee, WI) for further analysis.
The pig studies yielded useful ultrasound imagingguidance indicators while simultaneous tissue ablation was performed using a separate ablation catheter with 50 Watts of RF power delivery capability. Both the sidelooking HockeyStick catheter (Figs. 1, 4, and 6 ) and the forward-looking MicroLinear catheter designs (Figs. 2, 3 , and 5) were successful in the imaging of therapeutic RF catheter ablations. The HockeyStick catheter was tested in color flow mode, successfully imaging both the aortic outflow track and LA pulmonary vein dynamic blood flow. The short axis view of the LV from the RA in the pig of Fig. 6 shows the ability of the HockeyStick to track tissue synchrony using the high frame rate SRI modality available on the imaging system platform. Cardiac arrhythmias were induced by using external pacing leads to alter the patterns of normal sinus rhythm.
Experiments with HockeyStick ICE catheter and electroanatomical mapping catheter integration have been completed. The EP sensor connector of the HockeyStick ICE catheter was connected directly to the NavX sys-tem, which allowed both the HockeyStick and the NavX catheter to be visualized simultaneously on the NavX system. Fig. 1 shows the HockeyStick on the right side of the heart in the RA while the NavX catheter is shown in the LV after completing the 3-D mapping of that chamber.
IV. Discussion
A. Imaging Utility of Multifunctional ICE Catheters
Early animal studies targeted general B-Mode imaging of intracardiac features and ablation catheters with attention to evaluation of resynchronization pacing using the multifunctional nature of the EP-ICE combination catheters equipped with integrated EP sensors. The EP-ICE catheters were usually advanced to the heart to perform studies of the RA and RV without fluoroscopic guidance. In one animal, the EP-ICE catheter entered the patent foramen ovale in the intra-atrial septal wall and entered the LA without difficulty. Clear delineation of bubble production after prolonged RF ablation was observed. Both the side-looking HockeyStick catheter and the forward-looking MicroLinear catheter designs have been successful in obtaining very useful images of therapeutic RF catheter ablations.
The HockeyStick has been used very successfully to track tissue synchrony using the high frame rate SRI modality available on the imaging system platform. This ability can be valuable in the assessment of cardiac arrhythmias. High frame rate SRI imaging allows a mechanical survey of the effects of the electrical activation and improves the ability to detect early contractions in the monitored regions of the myocardium that move first using this tissue-tracking technique.
B. Imaging with 3-D Electroanatomical Guidance
Individual intracardiac ECG channel evaluations of arrhythmias have evolved toward simultaneous, multichannel mapping, producing much more detail in the temporal characterization of specific arrhythmias. With the sheer bulk and complexity of the temporo-spatial information, it has become increasingly more difficult to maintain a clear perspective on the large number of channels of ECG data and as well interpret their significance with respect to their specific anatomic locations. Within the last decade, the development of computer-based mapping that better records and presents both the spatial and temporal characteristics of cardiac activity has become more popular as a natural solution to this issue, and in particular as it addresses the need for procedural guidance of therapeutic ablation treatments for problems related to arrhythmias.
Electro-anatomical mapping in particular has become a significant guidance tool. The technique uses patientisolated electrical field gradients established by a set of patch electrodes attached to the patient's body in at least 5 key positions. The electrical field gradients can be sensed by either a single electrode on a single intracardiac catheter or on as many as 64 electrodes from many different catheters. The system can determine the location of any single electrode to a spatial accuracy in the range of ±1 mm with a temporal sampling rate as high as 1200 per second [31] , [34] . The key enabling feature of this technology is its adaptability; the only particular requirement for our ICE-imaging catheter is the feature of EP electrodes on the catheter tip with a wire path to a connector compatible with the electroanatomical system inputs.
A series of pre-clinical studies have been performed that have combined ICE imaging capability with catheter localization and tracking in 3-D space in real time. Following an initial volumetric mapping with the NavX catheter, the HockeyStick catheter itself could be tracked continuously within the volume, and with the multiple electrode feature the orientation of the ICE catheter could also be placed accurately in the intracardiac chamber. Since the HockeyStick has a separate EP connector to allow for ECG signal monitoring, the electrodes connected to this EP connector allow for a very easy means of connection to the NavX system connectors. It is only this simple interconnect that is necessary for the NavX system to track the electrode positions in 3-D space. This capability can potentially yield a very powerful strategy to enhance the clinical utility of ICE by enabling therapeutic procedures, guided by intracardiac echocardiography, with much less dependence on hazardous fluoroscopic image guidance. In one of our studies, the navigation and manipulation time for achieving ultrasound imaging of an ablation procedure was substantially reduced by more than 75% compared with fluoroscopic visualization only.
V. Conclusions
Future intracardiac therapies will likely include devices that have multiple capabilities that can improve clinical outcomes with superior guidance features and less dependence on fluoroscopy with its potential for hazardous radiation exposure.
A 3-D road map projection of the heart anatomy through the use of electroanatomical mapping can be successfully combined with ICE catheters in a very seamless fashion, which portends a great future for the success of this technology integration. The future combination of electroanatomical mapping and ICE may offer a significant means for improving the identification accuracy of therapeutic targets, lessen the lengthy procedural times, and decrease the dependence on potentially hazardous fluoroscopic guidance.
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